Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹18,051Cr
Rev Gr TTM
Revenue Growth TTM
21.48%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

CHAMBLFERT
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 8.8 | -23.3 | -37.3 | -47.6 | -26.6 | -11.7 | -19.3 | 13.1 | -7.3 | 15.5 | 47.5 | 19.9 |
| 3,487 | 4,956 | 4,771 | 3,720 | 2,477 | 4,181 | 3,556 | 4,140 | 2,285 | 4,937 | 5,571 | 5,078 |
Operating Profit Operating ProfitCr |
| 3.1 | 11.3 | 11.4 | 14.4 | 6.3 | 15.2 | 18.2 | 15.8 | 6.7 | 13.4 | 13.1 | 13.9 |
Other Income Other IncomeCr | 38 | 14 | 90 | 151 | 73 | 86 | 80 | 95 | 86 | 79 | 88 | 36 |
Interest Expense Interest ExpenseCr | 67 | 55 | 46 | 36 | 36 | 40 | 1 | 7 | 0 | 2 | 1 | 1 |
Depreciation DepreciationCr | 76 | 77 | 78 | 79 | 78 | 82 | 83 | 83 | 82 | 84 | 87 | 88 |
| 6 | 516 | 581 | 664 | 126 | 716 | 786 | 783 | 168 | 754 | 842 | 768 |
| -88 | 177 | 200 | 205 | 29 | 268 | 249 | 248 | 37 | 205 | 193 | 182 |
|
Growth YoY PAT Growth YoY% | -61.5 | -0.9 | 38.9 | 41.8 | 3.0 | 32.4 | 40.8 | 16.3 | 34.6 | 22.4 | 20.9 | 9.7 |
| 2.6 | 6.1 | 7.1 | 10.6 | 3.7 | 9.1 | 12.3 | 10.9 | 5.3 | 9.6 | 10.1 | 9.9 |
| 2.3 | 8.1 | 9.2 | 11.0 | 2.5 | 11.2 | 13.4 | 13.3 | 3.3 | 13.7 | 16.2 | 14.6 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 9.3 | -7.5 | -16.1 | -0.2 | 33.9 | 20.9 | 4.2 | 26.3 | 72.8 | -35.3 | -7.3 | 22.9 |
| 9,004 | 8,252 | 6,777 | 6,745 | 8,882 | 10,304 | 10,256 | 13,807 | 25,953 | 15,923 | 14,163 | 17,871 |
Operating Profit Operating ProfitCr |
| 7.5 | 8.4 | 10.3 | 10.6 | 12.0 | 15.6 | 19.4 | 14.1 | 6.5 | 11.4 | 14.9 | 12.6 |
Other Income Other IncomeCr | 105 | 49 | 136 | 181 | -2 | 215 | 475 | 374 | 225 | 330 | 347 | 289 |
Interest Expense Interest ExpenseCr | 163 | 266 | 254 | 155 | 246 | 503 | 289 | 106 | 320 | 173 | 48 | 4 |
Depreciation DepreciationCr | 216 | 111 | 92 | 85 | 119 | 287 | 289 | 300 | 308 | 313 | 330 | 341 |
| 459 | 428 | 566 | 737 | 846 | 1,328 | 2,360 | 2,231 | 1,416 | 1,887 | 2,452 | 2,531 |
| 180 | 160 | 186 | 245 | 247 | 101 | 612 | 665 | 383 | 611 | 802 | 617 |
|
| 19.2 | -4.3 | 42.0 | 29.4 | 21.7 | 104.9 | 42.5 | -10.4 | -34.0 | 23.4 | 29.3 | 16.1 |
| 2.9 | 3.0 | 5.0 | 6.5 | 5.9 | 10.1 | 13.7 | 9.8 | 3.7 | 7.1 | 9.9 | 9.4 |
| 7.1 | 5.3 | 8.7 | 12.0 | 14.2 | 29.5 | 39.8 | 37.6 | 24.9 | 30.8 | 41.2 | 47.8 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 414 | 416 | 416 | 416 | 416 | 416 | 416 | 416 | 416 | 401 | 401 | 401 |
| 1,837 | 1,468 | 1,725 | 2,104 | 2,478 | 3,131 | 4,837 | 5,986 | 6,652 | 6,873 | 8,327 | 9,438 |
Current Liabilities Current LiabilitiesCr | 4,108 | 5,008 | 4,391 | 3,309 | 6,525 | 6,678 | 1,525 | 3,802 | 3,152 | 2,037 | 1,174 | 2,528 |
Non Current Liabilities Non Current LiabilitiesCr | 1,225 | 1,326 | 1,625 | 3,736 | 4,616 | 4,423 | 3,485 | 3,101 | 2,565 | 2,214 | 1,521 | 1,504 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 4,430 | 5,256 | 4,870 | 3,773 | 6,505 | 7,325 | 3,148 | 6,075 | 5,639 | 4,089 | 3,622 | 5,743 |
Non Current Assets Non Current AssetsCr | 3,208 | 2,868 | 3,187 | 5,690 | 7,421 | 7,207 | 7,099 | 7,214 | 7,131 | 7,420 | 7,785 | 8,109 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1,064 | -27 | 1,280 | 1,172 | -1,130 | 827 | 6,944 | -24 | 3,239 | 3,327 | 1,394 |
Investing Cash Flow Investing Cash FlowCr | -140 | -339 | -691 | -1,778 | -1,125 | -455 | -196 | -119 | -1,873 | -382 | 739 |
Financing Cash Flow Financing Cash FlowCr | -937 | 362 | -500 | 564 | 2,263 | -283 | -6,007 | -213 | -1,862 | -2,871 | -2,135 |
|
Free Cash Flow Free Cash FlowCr | 878 | -665 | 400 | -1,250 | -2,334 | 177 | 6,709 | -186 | 3,046 | 2,720 | 825 |
| 380.6 | -9.9 | 336.6 | 238.3 | -188.8 | 67.4 | 397.3 | -1.6 | 313.3 | 260.8 | 84.5 |
CFO To EBITDA CFO To EBITDA% | 145.0 | -3.5 | 164.8 | 147.1 | -93.2 | 43.5 | 281.9 | -1.1 | 178.0 | 162.8 | 56.1 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 2,809 | 2,283 | 3,602 | 6,768 | 6,930 | 4,499 | 9,523 | 17,564 | 10,990 | 13,706 | 25,065 |
Price To Earnings Price To Earnings | 10.0 | 10.3 | 9.9 | 13.6 | 11.7 | 3.7 | 5.8 | 11.2 | 10.6 | 10.7 | 15.2 |
Price To Sales Price To Sales | 0.3 | 0.3 | 0.5 | 0.9 | 0.7 | 0.4 | 0.8 | 1.1 | 0.4 | 0.8 | 1.5 |
Price To Book Price To Book | 1.2 | 1.2 | 1.7 | 2.7 | 2.4 | 1.3 | 1.8 | 2.7 | 1.6 | 1.9 | 2.9 |
| 8.7 | 9.6 | 10.4 | 16.0 | 12.8 | 7.2 | 5.1 | 9.4 | 7.8 | 7.6 | 10.0 |
Profitability Ratios Profitability Ratios |
| 41.9 | 35.5 | 37.0 | 38.6 | 39.8 | 43.6 | 42.3 | 40.2 | 29.1 | 39.3 | 44.0 |
| 7.5 | 8.4 | 10.3 | 10.6 | 12.0 | 15.6 | 19.4 | 14.1 | 6.5 | 11.4 | 14.9 |
| 2.9 | 3.0 | 5.0 | 6.5 | 5.9 | 10.1 | 13.7 | 9.8 | 3.7 | 7.1 | 9.9 |
| 10.3 | 10.1 | 12.1 | 10.4 | 9.4 | 14.1 | 28.8 | 21.8 | 16.6 | 22.5 | 28.3 |
| 12.4 | 14.2 | 17.8 | 19.5 | 20.7 | 34.6 | 33.3 | 24.5 | 14.6 | 17.5 | 18.9 |
| 3.7 | 3.3 | 4.7 | 5.2 | 4.3 | 8.4 | 17.1 | 11.8 | 8.1 | 11.1 | 14.5 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Chambal Fertilisers & Chemicals Ltd (CFCL) is a leading Indian manufacturer of nitrogenous fertilizers and a growing player in crop protection chemicals (CPC), specialty nutrients (SN), and sustainable agri-inputs. The company operates three urea plants at its integrated site in Gadepan, Kota (Rajasthan), with a combined annual capacity of **3.4 million metric tons (MTPA)** — approximately **12% of India’s domestic urea production**. CFCL markets a diverse portfolio under its trusted **“Uttam”** brand across 13 Indian states and one union territory, serving over 90% of the market in North, West, Central, and Southern India through a robust network of ~4,200 dealers and 60,000 retailers.
---
### **Core Business Segments**
#### **1. Urea & Bulk Fertilizers**
- **Stable Anchor Business:** Urea remains the company's core revenue generator, contributing consistent margins and enabling financial stability.
- The company produces ~9.2 lakh MT per quarter, with all plants operating at optimal levels. Energy efficiency has improved by **2–3%** post-turnaround at Plants I and II.
- In addition to urea, CFCL distributes DAP, MOP, and NPK fertilizers, with NPK sales growing significantly, particularly in southern and western states like Maharashtra, Andhra Pradesh, Telangana, and Gujarat.
#### **2. Crop Protection Chemicals (CPC) & Specialty Nutrients (SN)**
- A **high-growth segment**, achieving a **24% CAGR in revenue over the past three years** (INR 154 crore in FY20-21 → INR 309 crore in FY22-23).
- The business saw **double-digit revenue growth in FY2024-25**, including an **80% YoY increase from new territories** and an **214% surge in CPC revenue from new geographies**.
- CFCL sources formulations from third-party toll manufacturers and markets them under proprietary brands, leveraging its strong distribution and brand equity.
- Currently offers **61–62 products** in herbicides, fungicides, and insecticides, with 12 new CPC/SN products launched in FY2024-25 alone.
#### **3. Biologicals – A Strategic Growth Vector**
- CFCL has made a major pivot toward sustainable agriculture:
- Launched **UTTAM PRANAAM**, a **bio-nano phosphorus liquid fertilizer (10% P2O5)**, which sold **200,000+ bottles by Sept 2024**, and is gaining steady acceptance.
- **SUPERRHIZA**, a **mycorrhizal biofertilizer**, won **“International Biological Product of the Year 2023”** from Applied Microbiology International, with **72% revenue growth in H1 FY25**.
- Strong traction in the biologicals segment supports India’s **BioE3 and PM PRANAM missions**.
- Plans to launch **biological fungicides and nematicides** following successful internal trials.
#### **4. Entry into Seeds Business (Kharif 2025)**
- CFCL is expanding into **hybrid and research-variety seeds** (targeting wheat, mustard, millet), completing a **full “seed-to-harvest” agri-input solution**.
- Positioned for **integrated product bundling** and deeper farmer engagement.
---
### **Strategic Expansion & Capex Projects**
#### **Technical Ammonium Nitrate (TAN) Plant – Flagship Capex Initiative**
- **Project Investment:** ₹1,645 crore
- **Capacity:**
- **240,000 MTPA Technical Ammonium Nitrate (TAN)**
- **210,000 MTPA Weak Nitric Acid (WNA)**
- **Technology:** Licensed from **CASALE, Switzerland**
- **Contractor:** **Larsen & Toubro Ltd** under lump-sum turnkey (LSKT) contract
- **Feedstock:** Utilizes **surplus ammonia** from existing fertilizer plants (*forward integration strategy*)
- **Modifications:**
- Warm ammonia feed to improve efficiency
- Provisions for future **Low-Density Ammonium Nitrate (LDAN)** production
- **Status:** Under construction at **Gadepan, Rajasthan**; all regulatory approvals secured; long-lead items procured.
- **Commercial Start:** **January 2026**
- **ROCE Expectation:** **15–17%** annually
- **Demand Outlook:** TAN demand expected to grow at **8–10% CAGR (FY22–FY30)** in coal, mining, and infrastructure sectors.
> **Note:** Initial timeline (Aug 2024) suggested October 2025, but later updates shifted start to January 2026, likely due to operational optimization.
---
### **Innovation & Sustainability Initiatives**
#### **CFCL-TERI Centre of Excellence**
- **Partnership with The Energy and Resources Institute (TERI)**, funded by CFCL for 5 years.
- **Goals:** Develop sustainable alternatives to chemical inputs — nano-fertilizers, biopesticides, mycorrhizal fungi, bio-stimulants.
- **IP Rights:** Joint development with **exclusive global commercial rights** held by CFCL.
- Focus on **high-value crops** (fruits, vegetables, niche crops) and **soil health improvement**.
#### **Strategic Alliances & Sourcing**
- Marketing partnerships with **innovator firms in Japan, US, Europe, and the Middle East** for access to advanced chemistries.
- **P2P (Partner-to-Partner)** sourcing agreements with global suppliers for off-patent generics.
- Collaborations with **Gen 1X** and other patented product innovators.
#### **R&D Pipeline**
- Focused on **nano-biotechnology, microbial solutions, and biogenic molecules**.
- Pipeline includes **water-soluble fertilizers**, **biostimulants**, and next-gen **formulation delivery systems**.
- Aiming for **₹300–400 crore in biologicals sales** over the medium term, with **commercial product launches expected between 2026–2029**.
---
### **Distribution & Farmer Engagement**
#### **Seed to Harvest (S2H) Program**
- Flagship farmer engagement model combining **digital + physical outreach**:
- **Digital platforms** and social media marketing
- Over **3,800 farmer meetings**, **3,000 field demos**, and **4 soil sampling days** (2,000+ samples collected)
- Total of **58,000 soil samples analyzed** for precision farming recommendations
- “**Hello Uttam**” helpline resolved **10,000+ queries** on dosage, pests, and crop care
- Reaches over **230,000 farmers annually** and supports **brand loyalty and education**.
#### **Market Penetration Goals (FY2026–27)**
- Target **25% market width (~₹10,500 crore)** and **17% market depth (~₹1,750 crore)** in CPC/SN segments.
- Expansion into **fruits, vegetables, and high-value crops** is central to the strategy.
---
### **Subsidiaries & Joint Ventures**
- **Subsidiaries:**
- CFCL Ventures Limited
- Chambal Infrastructure Ventures Limited
- ISGN Corporation
- ISG Novasoft Technologies Limited
- **Joint Venture:**
- **Indo Maroc Phosphore S.A. (IMACID)** – Produces phosphoric acid and fertilizers.
- **Production:** 525,000 tons (up from 435,000)
- **Sales:** 435,000 tons (up from 380,000)
- Benefited from lower input costs in FY25.
---
### **Financial & Operational Highlights**
- **Revenue Drivers:**
- Strong demand across **urea, NPK, CPC, and SN** segments
- Geographic expansion, especially in **NPK-reliant southern states**
- **Liquidity:** ~**60–65% of sales are cash-based**, supporting strong working capital position.
- **Growth Strategy:**
- Expand **non-subsidized fertilizer business** (CPC, SN, biologicals) to reduce dependency on government subsidies.
- Scale high-margin, sustainable product categories.